FIELD: pharmacy.
SUBSTANCE: antineoplastic preparation which coordination compound on the magnesium gluconate base wherein the ligands are chosen from the group consisting of γ-aminobutyric acid (GABA), 3-hydroxy-GABA, ethylendiaminotetraacetic acid and ethylenglycoltetraacetic acid or binary salt chosen from the group consisting of magnesium butyrogluconate, oxymagnesium butyrogluconate, magnesium glucarate-gluconate, calcium butyrogluconate, calcium oxybutyrogluconate, calcium glucarate-gluconate and their combinations.
EFFECT: claimed preparations exert the apoptotic and antiproliferative effect retaining the civilised cells.
4 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-ARRHYTHMIC PREPARATION | 2002 |
|
RU2223759C1 |
| MEDICATION FOR ERECTILE DISFUNCTION TREATMENT | 2005 |
|
RU2336878C2 |
| GLUTAMYLTRYPTOPHAN METALOCOMPLEXES WHICH REVEAL IMMUNOSTIMULATING PROPERTIES AND METHOD FOR THEIR OBTAINING | 1999 |
|
RU2181124C2 |
| ANTICANCER PHARMACEUTICAL COMPOSITION (VERSIONS) AND APPLICATION THEREOF | 2005 |
|
RU2396274C2 |
| ((3Β-ACETOXY-URS-12-EN-28-OYL-OXYACETOXY)METHYL)-1H-1,2,3-TRIAZOL-1-YL)METHYL)-4-METHYL-1,2,5-OXADIAZOL-2-OXIDE, HAVING SELECTIVE ANTICANCER ACTIVITY AGAINST MCF-7 BREAST CANCER CELLS | 2020 |
|
RU2739559C1 |
| POTASSIUM SALTS OF DIFFERENT-LIGAND COORDINATION COMPOUNDS OF MAGNESIUM WITH HISTIDINE, ADENOSINE-5'-TRIPHOSPHATE AND CREATINE PHOSPHATE SHOWING PROTECTIVE EFFECT ON MYOCARDIUM AGAINST ISCHEMIC DAMAGE | 1997 |
|
RU2144922C1 |
| PEPTIDE REPRESENTING ANALOG OF ALPHA-FETOPROTEIN FRAGMENT, CONJUGATE OF PEPTIDE WITH DOXORUBICIN AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF FOR TREATMENT OF ONCOLOGY DISEASE | 2006 |
|
RU2317102C1 |
| METHOD FOR PRODUCING NANOSTRUCTURED DOUBLE HYDROXIDES BASED ON ALUMINIUM AND ALKALINE EARTH METALS SUCH AS MAGNESIUM OR CALCIUM, EXHIBITING THE PROPERTY OF INCREASING THE pH OF A CELLULAR MEDIUM, AND NANOSTRUCTURES PRODUCED THEREBY | 2020 |
|
RU2758671C1 |
| ANTITUMOR AGENTS BASED ON MACRO- AND MICROELEMENT-CONTAINING POLYGALACTURONATES (OPTIONS) | 2022 |
|
RU2792613C1 |
| INJECTIONAL FORM OF PREPARATION OF ANTIISCHEMIC ACTIVITY | 1999 |
|
RU2190411C2 |
